Nutex Health or HCA Healthcare: Which Stock Has More Upside?
HCA Healthcare fell -8.8% during the past Day. You may be tempted to buy more, or may want to reduce your exposure. But there is an entirely different perspective you might be missing. Is there a better alternative? Turns out, its peer Nutex Health gives you more. Nutex Health (NUTX) stock offers superior revenue growth across key periods, better profitability, and relatively lower valuation vs HCA Healthcare (HCA) stock, suggesting you may be better off investing in NUTX
- NUTX’s Last 12 Months revenue growth was 82.4%, vs. HCA’s 7.1%.
- In addition, its Last 3-Year Average revenue growth came in at 63.0%, ahead of HCA’s 7.9%.
- NUTX leads on profitability over both periods – LTM margin of 31.5% and 3-year average of 19.9%.
These differences become even clearer when you look at the financials side by side. The table highlights how HCA’s fundamentals stack up against those of NUTX on growth, margins, momentum, and valuation multiples.
Valuation & Performance Overview
| HCA | NUTX | Preferred | |
|---|---|---|---|
| Valuation | |||
| P/EBIT Ratio | 8.2 | 2.8 | NUTX |
| Revenue Growth | |||
| Last Quarter | 6.7% | -41.1% | HCA |
| Last 12 Months | 7.1% | 82.4% | NUTX |
| Last 3 Year Average | 7.9% | 63.0% | NUTX |
| Operating Margins | |||
| Last 12 Months | 15.8% | 31.5% | NUTX |
| Last 3 Year Average | 15.2% | 19.9% | NUTX |
| Momentum | |||
| Last 3 Year Return | 54.7% | 16.4% | HCA |
Note: For “Last 3 Year Return” metric, preferred stock is one with higher returns unless the returns are too high (>300%) which creates risk of sell off.
- META Stock: The Math Behind The Upside
- TSLA Stock: 4 Impending Events That Could Invalidate the Thesis
- Could This Fuel The Next Surge in Intel Stock
- EPAM Systems Stock: Strong Cash Flow Poised for a Re-Rating?
- Comcast Stock Shares $24 Bil Success With Investors
- 3M Stock Pays Out $24 Bil – Investors Take Note
See detailed fundamentals on Buy or Sell NUTX Stock and Buy or Sell HCA Stock. Below we compare market return and related metrics across years.
Historical Market Performance
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | Avg | Best | |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| HCA Return | 58% | -6% | 14% | 12% | 57% | 2% | 201% | <=== | |
| NUTX Return | 0% | 35% | -91% | 17% | 419% | -34% | -48% | ||
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 4% | 89% | ||
| Monthly Win Rates [3] | |||||||||
| HCA Win Rate | 67% | 50% | 58% | 58% | 67% | 75% | 62% | <=== | |
| NUTX Win Rate | 0% | 42% | 17% | 50% | 58% | 25% | 32% | ||
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | 62% | ||
| Max Drawdowns [4] | |||||||||
| HCA Max Drawdown | -5% | -35% | -7% | 0% | -1% | -1% | -8% | <=== | |
| NUTX Max Drawdown | 0% | -61% | -91% | -84% | -3% | -47% | -48% | ||
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -7% | -9% | ||
[1] Cumulative total returns since the beginning of 2021
[2] 2026 data is for the year up to 4/24/2026 (YTD)
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
No matter how good the numbers, stock investment is never a smooth ride. There is a risk you must factor in. Read NUTX Dip Buyer Analyses and HCA Dip Buyer Analyses to see how these stocks have fallen and recovered in the past.
Still not sure about HCA or NUTX? Consider portfolio approach.
Portfolios Over Individual Stock Picks
Individual stocks are unpredictable. A smart portfolio helps you invest, limits downside shocks, and provides upside exposure.
Why settle for average market returns? The Trefis High Quality (HQ) Portfolio invests in a diverse group of 30 stocks that have collectively delivered stronger upside with reduced volatility compared to the broader indices. Discover the methodology behind these smoother, higher returns by checking the HQ Portfolio performance data.